|
시장보고서
상품코드
2058257
PoC(Point-of-Care) 감염증 진단 시장 : 기술별, 용도별, 최종 사용자별, 지역별Point Of Care Infectious Disease Diagnostics Market, By Technology, By Application, By End User, By Geography |
||||||
PoC(Point-of-Care) 감염증 진단 시장은 2026년에 68억 3,440만 달러에 달하고 2033년까지 176억 3,350만 달러에 이를 것으로 예상되고 있습니다. 2026-2033년 CAGR은 14.7%를 나타낼 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 시장 규모(2026년) : | 68억 3,440만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 14.70% | 시장 규모 예측(2033년) : | 176억 3,350만 달러 |
아프리카(서아프리카), 인도, 브라질, 중국 등 신흥국에서는 중앙집권적인 검사 시설이 제한적입니다. 신흥국에서는 검사실 및 인프라 부족, 관련 비용, 그리고 훈련된 인력 부족으로 인해 현장 진단이 필요로 하고 있습니다. 현장 진단 검사의 대부분은 비교적 시행하기 쉬우며, 최소한의 훈련만으로도 실시할 수 있습니다. HIV, 말라리아, 결핵 등의 감염병은 이러한 신흥 경제국에서 매우 만연해 있어, 현장 진단 검사가 필수적입니다. 또한, 이러한 지역에서는 감염병 유행이 매우 빈번하게 발생하고 있는데, 예를 들어 2017년 12월 나이지리아와 같은 해 11월 브라질에서 황열병 유행이, 2017년 7월에는 나이지리아에서 급성 E형 간염 유행이 관찰된 바 있습니다. 이러한 상황에서 현장 진단은 유용할 것으로 예측됩니다.
시장 역학
신속한 진단을 가능하게 하는 기술적 진보(혁신적인 검사법)와 제조업체가 제공하는 광범위한 현장 감염증 진단 제품 포트폴리오가 PoC(Point-of-Care) 감염증 진단 시장의 성장을 뒷받침하고 있습니다. 감염병을 위한 혁신적인 현장 진단법 개발, 외딴 지역에서의 폭넓은 적용, 끊이지 않는 감염병 유행, 그리고 제품 개발 및 연구 개발에 대한 정부의 재정 지원이 시장 성장을 견인할 것으로 예측됩니다. 외딴 지역에서의 감염병 현장 진단(Point-of-Care) 도입 확대, 수량 주도형 성장, 그리고 HIV 등 감염병 유병률 상승에 힘입어, 이 시장은 상당한 성장을 이룰 것으로 예측됩니다. 한편, 신흥국에서의 재고 문제나 부적절한 관리로 인한 공급 부족, 그리고 결과의 신뢰성 문제가 시장 성장을 저해하는 요인이 될 것으로 보입니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 성장 촉진요인, 시장 성장 억제요인, 기회, 신제품 출시 및 승인, 지역별 전망, 그리고 주요 기업들이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 주요 지표를 바탕으로 세계 PoC(Point-of-Care) 감염증 진단 시장의 주요 기업 프로파일을 작성하였습니다. 기업 개요, 재무 실적, 제품 포트폴리오, 사업 전개 지역, 유통 전략, 주요 발전 사항 및 전략.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 기술 업그레이드, 시장 확대 및 마케팅 전략에 대해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 본 '세계의 PoC(Point-of-Care) 감염증 진단 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진출기업, 금융 애널리스트 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 PoC(Point-of-Care) 감염증 진단 시장 분석에 활용된 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 내릴 수 있을 것입니다.
목차
제1장 조사 목적 및 전제 조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 PoC(Point-of-Care) 감염증 진단 시장 : 기술별(2021-2033년)
제5장 세계의 PoC(Point-of-Care) 감염증 진단 시장 : 용도별(2021-2033년)
제6장 세계의 PoC(Point-of-Care) 감염증 진단 시장 : 최종 사용자별(2021-2033년)
제7장 세계의 PoC(Point-of-Care) 감염증 진단 시장 : 지역별(2021-2033년)
제8장 경쟁 구도
제9장 섹션
KTH 26.06.19Point Of Care Infectious Disease Diagnostics Market is estimated to be valued at USD 6,834.4 Mn in 2026 and is expected to reach USD 17,633.5 Mn by 2033, growing at a compound annual growth rate (CAGR) of 14.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 6,834.4 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 14.70% | 2033 Value Projection: | USD 17,633.5 Mn |
Emerging economies such as Africa (West Africa), India, Brazil, and China have limited centralized laboratory facilities. In emerging economies point of care diagnostic is needed due to unavailability of labs, infrastructure, associated costs, and trained personnel. Most of the point-of-care diagnostic tests are comparatively easy to perform and can be performed with minimum amount of training. Infectious diseases such as HIV, Malaria, Tuberculosis, and others are highly prevalent in these emerging economies wherein point-of-care testing is a necessity. Furthermore, disease outbreaks are very frequent in these regions such as Yellow Fever disease outbreak in Nigeria and Brazil in December and November 2017, respectively and Acute Hepatitis E disease outbreak in Nigeria in July 2017, wherein point of care diagnostics could be helpful.
Market Dynamics
Technological advancements (innovative assays) to facilitate speedy diagnosis and extensive product portfolios of point of care infectious disease diagnostics offered by manufacturer's supports the growth of Point of Care Infectious Disease Diagnostics Market. Development of innovative point-of-care diagnostics for infectious diseases, wide applications in remote locations, constant disease outbreaks, and government funding for product development and research is expected to fuel growth of the market. The market is expected to gain significant growth, owing to increasing adoption of point-of-care diagnostics for infectious disease in remote locations, volume driven growth, and rising prevalence of infectious diseases such as HIV. Limited availability in emerging economies due to inventory issues and improper management, and result reliability issues are expected to hinder the market growth.
Key features of the study
- It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
- It profiles leading players in the global point of care infectious disease diagnostics market based on the following parameters - company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies
- Key companies covered as a part of this study include Danaher Corporation, Abbott Laboratories, Acon Laboratories, Inc., Hoffman-La Roche Ltd., Becton, Dickinson, and Company, Trinity Biotech Plc, AccuBioTech Co., Ltd. and Cardinal Health, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
- The global point of care infectious disease diagnostics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the point of care infectious disease diagnostics market
Market Segmentation
- By Technology (Revenue, USD Mn, 2021-2033)
- Lateral Flow
- Agglutination Assays
- Flow-Through
- Solid Phase
- By Application (Revenue, USD Mn, 2021-2033)
- HIV
- Tropical Disease
- Liver Disease
- Inflammatory Disease
- Respiratory Disease
- Hospital Associated Infections (HAIs)
- Sexual Health Disorders
- Others
- By End User (Revenue, USD Mn, 2021-2033)
- Hospitals
- Home-Care Settings
- Diagnostic Laboratories
- Others
- By Region (Revenue, USD Mn, 2021-2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC
- Israel
- Rest of Middle East
- Africa
- South Africa
- Central Africa
- North Africa
- Competitive Landscape
- Danaher Corporation
- Abbott Laboratories
- Alcon Laboratories, Inc.
- Hoffman-La Roche Ltd.
- Becton, Dickinson, and Company
- Trinity Biotech Plc
- AccuBioTech Co., Ltd.
- Cardinal Health, Inc.
Table of Contents
1. Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Technology
- Market Snippet, By Application
- Market Snippet, By End User
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- PEST Analysis
4. Global Point of Care Infectious Disease Diagnostics Market, By Technology, 2021 - 2033 (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Lateral Flow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Agglutination Assays
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Flow-Through
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Solid Phase
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
5. Global Point of Care Infectious Disease Diagnostics Market, By Application, 2021 - 2033 (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- HIV
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Tropical Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Liver Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Inflammatory Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Respiratory Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Hospital Associated Infections (HAIs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Sexual Health Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
6. Global Point of Care Infectious Disease Diagnostics Market, By End User, 2021 - 2033 (USD Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Home-Care Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Mn)
7. Global Point of Care Infectious Disease Diagnostics Market, By Regions, 2021 - 2033 (USD Mn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022 - 2033
- North America
- Market Size and Forecast, By Technology, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Technology, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Technology, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of APAC
- Latin America
- Market Size and Forecast, By Technology, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Mn)
- Brazil
- Mexico
- Rest of Latin America
- Africa
- Market Size and Forecast, By Technology, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Mn)
- Central Africa
- South Africa
- North Africa
- Middle East
- Market Size and Forecast, By Technology, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By Application, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By End User, 2021 - 2033 (USD Mn)
- Market Size and Forecast, By Country, 2021 - 2033 (USD Mn)
- GCC
- Israel
- Rest of Middle East
8. Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Danaher Corporation
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Abbott Laboratories
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Acon Laboratories, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hoffman-La Roche Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Becton, Dickinson, and Company
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Trinity Biotech Plc
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AccuBioTech Co., Ltd.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cardinal Health, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Danaher Corporation
9. Section
- References
- Research Methodology
- About us and Sales Contact
